Literature DB >> 29868132

We Need CARs More and More.

Mircea Cinteza1,2.   

Abstract

Year:  2018        PMID： 29868132      PMCID： PMC5972784     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN： 1841-9038


× No keyword cloud information.
  6 in total

1.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

Review 2.  Adoptive T cell therapy: An overview of obstacles and opportunities.

Authors:  Erez Nissim Baruch; Amy Lauren Berg; Michal Judith Besser; Jacob Schachter; Gal Markel
Journal:  Cancer       Date:  2017-06-01       Impact factor: 6.860

Review 3.  The Principles of Engineering Immune Cells to Treat Cancer.

Authors:  Wendell A Lim; Carl H June
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  CAR-T Cell Therapy: From the Bench to the Bedside.

Authors:  Vita Golubovskaya
Journal:  Cancers (Basel)       Date:  2017-10-31       Impact factor: 6.639

Review 5.  CAR-T cells: the long and winding road to solid tumors.

Authors:  Maria Michela D'Aloia; Ilaria Grazia Zizzari; Benedetto Sacchetti; Luca Pierelli; Maurizio Alimandi
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 6.  CAR T Cell Therapy: A Game Changer in Cancer Treatment.

Authors:  Hilde Almåsbak; Tanja Aarvak; Mohan C Vemuri
Journal:  J Immunol Res       Date:  2016-05-19       Impact factor: 4.818
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.